查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1615401

胃腸道藥物市場：按類型、疾病類型、給藥途徑、分銷管道、最終用戶分類 - 全球預測 2025-2030

Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胃腸道藥物市場價值為572.6億美元，預計2024年將達到600.6億美元，複合年成長率為4.97%，到2030年將達到804.7億美元。

胃腸道藥物市場包括多種緩解胃腸道疾病的藥物治療，例如制酸劑、質子幫浦抑制劑、止瀉、止瀉藥和抗組織胺藥物。由於胃腸道疾病的盛行率不斷增加、生活方式的改變導致腸道健康狀況不佳，以及人口老化增加了胃腸道疾病的易感性，因此對這些藥物的需求更加突出。這些藥物可治療胃食道逆流、克隆氏症和大腸激躁症等多種疾病，並且具有處方藥和非處方藥兩種用途。由於對有效治療解決方案的需求不斷成長，最終用戶的範圍從醫院、診所到居家醫療。

主要市場統計
基準年[2023] 572.6億美元
預計年份 [2024] 600.6億美元
預測年份 [2030] 804.7億美元
複合年成長率（%） 4.97%

由於醫療保健意識的提高、藥物研究的進步以及醫療設施的改善，新興市場的需求激增對市場成長產生了重大影響。隨著新的治療方案不斷發展，治療機會正在擴大，特別是在生物製藥和個人化醫療領域。此外，數位健康和​​電子商務平台的進步為市場滲透和消費者參與開闢了新途徑。然而，嚴格的監管標準、潛在的副作用以及高昂的研發成本等挑戰構成了障礙。市場飽和狀態（尤其是新興市場）和學名藥競爭也使成長變得複雜。

未來性的創新研究領域包括基於微生物的治療方法、植物來源的藥物替代品以及奈米醫學等藥物傳輸系統的進展。結合這些創新將實現更有針對性和更有效的治療。該市場呈現出動態的特點，不斷湧入新療法以及活躍的產學界合作，旨在提高我們對胃腸道病理學的了解。建議企業透過投資於未滿足需求的研發、與監管機構合作簡化途徑以及利用數位平台來提高認知度和分銷來利用新興地區的巨大潛力，以克服市場限制並促進永續成長。

市場動態：揭示快速發展的胃腸道藥物市場的關鍵市場洞察

胃腸道藥物市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球胃腸道疾病盛行率不斷上升
    • 關於胃腸道健康和可用治療方法的教育宣傳活動
    • 健康保險覆蓋範圍和報銷政策的有利變化
  • 市場限制因素
    • 藥品生產所需原料供應中斷
  • 市場機會
    • 政府核准治療消化系統疾病的新療法
    • 持續研究和開發旨在創新配方和輸送系統
  • 市場挑戰
    • 與胃腸道藥物和補充品相關的副作用

波特五力：駕馭胃腸道藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胃腸道藥物市場的外部影響

外部宏觀環境因素對胃腸道藥物市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解胃腸道藥物市場競爭狀況

對胃腸道藥物市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣胃腸道藥物市場供應商績效評估

FPNV定位矩陣是評估胃腸道藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製胃腸道藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對胃腸道藥物市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球胃腸道疾病發生率上升
      • 關於胃腸道健康和可用治療方法的教育宣傳活動
      • 健康保險覆蓋範圍和報銷政策的有利變化
    • 抑制因素
      • 藥品生產所需原料供應中斷
    • 機會
      • 政府核准治療胃腸道疾病的新藥
      • 持續研究並開發創新藥物配方和輸送系統
    • 任務
      • 與胃腸道藥物和補充品相關的副作用
  • 市場區隔分析
    • 類型：隨著消費者健康意識的增強，營養食品的使用呈上升趨勢
    • 最終使用者：作為初始患者治療和持續管理計劃的一部分，胃腸道藥物在醫院和診所具有巨大的潛力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章胃腸道藥物市場：按類型

  • 食品補充品
  • 藥物
    • 制酸劑
    • 止瀉藥
    • 止吐藥
    • H2阻斷劑
    • 瀉藥
    • 質子幫浦抑制劑

第7章胃腸道藥物市場：依疾病類型

  • 便秘
  • 腹瀉
  • 胃食道逆流症
  • 發炎性腸道疾病
  • 大腸激躁症
  • 消化性潰瘍

第8章胃腸道藥物市場：依給藥途徑

  • 口服
  • 胃腸外的
  • 直腸

第9章胃腸道藥物市場：按分銷管道

  • 線下藥局
  • 網路藥房

第10章胃腸道藥物市場：依最終使用者分類

  • 居家護理
  • 醫院/診所

第11章 北美洲和南美胃腸道藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太胃腸道藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲胃腸道藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Calm & Focus 簡介：PLT Health Solutions 基於 Zembrin 和 GABA 的食品補充劑
    • Designs for Health 推出有益於女性健康的創新益生菌
    • 在 Target 商店推出 Wonder Berry 限量口味制酸劑
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • American Health
  • Amway Corporation
  • Archer-Daniels-Midland Company
  • ARKOPHARMA Laboratories, Company Limited
  • Bayer AG
  • Biomedical Research Laboratories, LLC
  • DuPont de Nemours, Inc.
  • Dymatize Enterprises LLC
  • FANCL Corporation
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Herbalife Nutrition Ltd.
  • Himalaya Wellness Company
  • Nature's Sunshine Products, Inc.
  • Nestle SA
  • Nutraceutical International Corporation
  • NutraScience Labs
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Pragati Biocare Pvt. Ltd.,
  • Procter & Gamble Health Limited
  • Pure Encapsulations, LLC.
  • Sabinsa Corporation
  • Sanofi SA
Product Code: MRR-CB04E056533F

The Gastrointestinal Agents Market was valued at USD 57.26 billion in 2023, expected to reach USD 60.06 billion in 2024, and is projected to grow at a CAGR of 4.97%, to USD 80.47 billion by 2030.

The gastrointestinal agents market encompasses a wide array of pharmacological treatments designed to alleviate disorders of the digestive tract, including antacids, proton pump inhibitors, laxatives, anti-diarrheals, and antihistamines for gastrointestinal use. The necessity of these agents is underscored by the rising prevalence of digestive disorders, lifestyle changes that contribute to poor gut health, and the aging population which is more susceptible to gastrointestinal ailments. These agents find applications in both prescription and over-the-counter segments, catering to diverse conditions such as GERD, Crohn's disease, irritable bowel syndrome, and more. End-users predominantly range from hospitals and clinics to home care settings, driven by the escalating demand for effective treatment solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 57.26 billion
Estimated Year [2024] USD 60.06 billion
Forecast Year [2030] USD 80.47 billion
CAGR (%) 4.97%

Market growth is significantly influenced by increased healthcare awareness, advancing pharmaceutical research, and burgeoning demand in emerging markets due to better access to healthcare facilities. Opportunities flourish particularly in biologic and personalized medicine sectors, as novel treatment options continue to evolve. Moreover, digital health advancements and e-commerce platforms are unlocking new avenues for market penetration and consumer engagement. However, challenges including stringent regulatory standards, potential side effects, and high R&D costs pose hindrances. A saturated market, particularly in developed regions, and generics competition also add layers of complexity to growth.

Innovation and research areas with substantial promise include microbiome-based therapies, plant-derived and alternative medicinal products, and advancements in drug delivery systems such as nanomedicine. Embracing these innovations can lead to more targeted and effective therapies. The market exhibits a dynamic nature, with a steady influx of novel therapeutics complemented by substantial industry-academia collaborations aimed at better understanding gastrointestinal pathophysiology. Companies are recommended to invest in R&D focused on unmet needs, engage with regulatory bodies to streamline pathways, and leverage digital platforms for awareness and distribution to capitalize on the massive potential in emerging regions, thereby overcoming market limitations and driving sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastrointestinal Agents Market

The Gastrointestinal Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of gastrointestinal disorders across the globe
    • Educational campaigns about gastrointestinal health and available treatments
    • Favorable changes in health insurance coverage and reimbursement policies
  • Market Restraints
    • Disruptions in the supply of raw materials required for drug manufacturing
  • Market Opportunities
    • Government approvals for new therapeutic agents to treat gastrointestinal disorders
    • Ongoing research and development aimed at innovative drug formulations and delivery systems
  • Market Challenges
    • Side effects associated with gastrointestinal drugs and supplements

Porter's Five Forces: A Strategic Tool for Navigating the Gastrointestinal Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastrointestinal Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastrointestinal Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastrointestinal Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastrointestinal Agents Market

A detailed market share analysis in the Gastrointestinal Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastrointestinal Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastrointestinal Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastrointestinal Agents Market

A strategic analysis of the Gastrointestinal Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Agents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Health, Amway Corporation, Archer-Daniels-Midland Company, ARKOPHARMA Laboratories, Company Limited, Bayer AG, Biomedical Research Laboratories, LLC, DuPont de Nemours, Inc., Dymatize Enterprises LLC, FANCL Corporation, Glanbia PLC, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Himalaya Wellness Company, Nature's Sunshine Products, Inc., Nestle S.A, Nutraceutical International Corporation, NutraScience Labs, Otsuka Holdings Co. Ltd., Pfizer Inc., Pragati Biocare Pvt. Ltd.,, Procter & Gamble Health Limited, Pure Encapsulations, LLC., Sabinsa Corporation, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Dietary Supplements and Drugs. The Drugs is further studied across Antacids, Anti-diarrheal Agents, Anti-emetics, H2 Blockers, Laxatives, and Proton Pump Inhibitors.
  • Based on Disease Type, market is studied across Constipation, Diarrhea, Gastroesophageal Reflux Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Peptic Ulcer Disease.
  • Based on Route of Administration, market is studied across Oral, Parenteral, and Rectal.
  • Based on Distribution Channel, market is studied across Offline Pharmacies and Online Pharmacies.
  • Based on End-User, market is studied across Homecare and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of gastrointestinal disorders across the globe
      • 5.1.1.2. Educational campaigns about gastrointestinal health and available treatments
      • 5.1.1.3. Favorable changes in health insurance coverage and reimbursement policies
    • 5.1.2. Restraints
      • 5.1.2.1. Disruptions in the supply of raw materials required for drug manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Government approvals for new therapeutic agents to treat gastrointestinal disorders
      • 5.1.3.2. Ongoing research and development aimed at innovative drug formulations and delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with gastrointestinal drugs and supplements
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of dietary supplements with an increasing number of health-conscious consumers
    • 5.2.2. End-User: High potential of gastrointestinal agents across hospitals & clinics as part of initial treatment and ongoing management plans for patients
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gastrointestinal Agents Market, by Type

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. Drugs
    • 6.3.1. Antacids
    • 6.3.2. Anti-diarrheal Agents
    • 6.3.3. Anti-emetics
    • 6.3.4. H2 Blockers
    • 6.3.5. Laxatives
    • 6.3.6. Proton Pump Inhibitors

7. Gastrointestinal Agents Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Constipation
  • 7.3. Diarrhea
  • 7.4. Gastroesophageal Reflux Disease
  • 7.5. Inflammatory Bowel Disease
  • 7.6. Irritable Bowel Syndrome
  • 7.7. Peptic Ulcer Disease

8. Gastrointestinal Agents Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral
  • 8.4. Rectal

9. Gastrointestinal Agents Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline Pharmacies
  • 9.3. Online Pharmacies

10. Gastrointestinal Agents Market, by End-User

  • 10.1. Introduction
  • 10.2. Homecare
  • 10.3. Hospitals & Clinics

11. Americas Gastrointestinal Agents Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gastrointestinal Agents Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gastrointestinal Agents Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Introduction of Calm & Focus: A Zembrin and GABA-Based Dietary Supplement by PLT Health Solutions
    • 14.3.2. Innovative Women's Health Probiotics Launched by Designs for Health
    • 14.3.3. Market Introduction of Wonderbelly Antacid with Exclusive Flavor at Target Stores
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. American Health
  • 3. Amway Corporation
  • 4. Archer-Daniels-Midland Company
  • 5. ARKOPHARMA Laboratories, Company Limited
  • 6. Bayer AG
  • 7. Biomedical Research Laboratories, LLC
  • 8. DuPont de Nemours, Inc.
  • 9. Dymatize Enterprises LLC
  • 10. FANCL Corporation
  • 11. Glanbia PLC
  • 12. GlaxoSmithKline PLC
  • 13. Herbalife Nutrition Ltd.
  • 14. Himalaya Wellness Company
  • 15. Nature's Sunshine Products, Inc.
  • 16. Nestle S.A
  • 17. Nutraceutical International Corporation
  • 18. NutraScience Labs
  • 19. Otsuka Holdings Co. Ltd.
  • 20. Pfizer Inc.
  • 21. Pragati Biocare Pvt. Ltd.,
  • 22. Procter & Gamble Health Limited
  • 23. Pure Encapsulations, LLC.
  • 24. Sabinsa Corporation
  • 25. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. GASTROINTESTINAL AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROINTESTINAL AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GASTROINTESTINAL AGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-DIARRHEAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-EMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2023